These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32259664)

  • 21. The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death.
    Tseng YT; Chang FR; Lo YC
    Phytomedicine; 2014 Apr; 21(5):724-33. PubMed ID: 24411708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buddlejasaponin IVb ameliorates ferroptosis of dopaminergic neuron by suppressing IRP2-mediated iron overload in Parkinson's disease.
    Li QM; Xu T; Zha XQ; Feng XW; Zhang FY; Luo JP
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117196. PubMed ID: 37717841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.
    Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH
    Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin protects rotenone-induced dopaminergic neurodegeneration by reducing lipid peroxidation.
    Ozbey G; Nemutlu-Samur D; Parlak H; Yildirim S; Aslan M; Tanriover G; Agar A
    Pharmacol Rep; 2020 Oct; 72(5):1397-1406. PubMed ID: 32207092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acrolein-mediated neuronal cell death and alpha-synuclein aggregation: Implications for Parkinson's disease.
    Ambaw A; Zheng L; Tambe MA; Strathearn KE; Acosta G; Hubers SA; Liu F; Herr SA; Tang J; Truong A; Walls E; Pond A; Rochet JC; Shi R
    Mol Cell Neurosci; 2018 Apr; 88():70-82. PubMed ID: 29414104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on preventive and therapeutic effects of Erzhi Pills on mice with Parkinson's disease induced by MPTP].
    Wu XF; Duan LX; Gao XL; Guo ML; Wang DM
    Zhongguo Zhong Yao Za Zhi; 2019 Oct; 44(19):4219-4224. PubMed ID: 31872702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
    Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P
    Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parkinson's disease a futile entangle of Mankind's credence on an herbal remedy: A review.
    Chang YM; Manoj Kumar M; Lu CY; Te Tsai C; Tsai CC; Liao PH; Lin SL; Chang CC; Mahalakshmi B; Kuo WW; Huang CY
    Life Sci; 2020 Sep; 257():118019. PubMed ID: 32629002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mechanism of traditional Chinese medicine on animal model of Parkinson's disease].
    Wu B; Zhao S; Wang X; Dong Q; Zheng G
    Zhongguo Zhong Yao Za Zhi; 2011 Sep; 36(18):2588-91. PubMed ID: 22256772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting ferroptosis with the lipoxygenase inhibitor PTC-041 as a therapeutic strategy for the treatment of Parkinson's disease.
    Minnella A; McCusker KP; Amagata A; Trias B; Weetall M; Latham JC; O'Neill S; Wyse RK; Klein MB; Trimmer JK
    PLoS One; 2024; 19(9):e0309893. PubMed ID: 39292705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin lowers α-synuclein phosphorylation and upregulates neurotrophic factor in the MPTP mouse model of Parkinson's disease.
    Katila N; Bhurtel S; Shadfar S; Srivastav S; Neupane S; Ojha U; Jeong GS; Choi DY
    Neuropharmacology; 2017 Oct; 125():396-407. PubMed ID: 28807678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
    Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
    Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Co-treatment with natural HMGB1 inhibitor Glycyrrhizin exerts neuroprotection and reverses Parkinson's disease like pathology in Zebrafish.
    Ren Q; Jiang X; Paudel YN; Gao X; Gao D; Zhang P; Sheng W; Shang X; Liu K; Zhang X; Jin M
    J Ethnopharmacol; 2022 Jun; 292():115234. PubMed ID: 35358621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroprotective effects of Suhexiang Wan on the in vitro and in vivo models of Parkinson's disease.
    Liu Q; Sang Heon K; Yung-Wei S; Sok Cheon P; Wonwoong L; Jongki H; Jaehwan J; Kyoung Sang C; Songhee J; Byung-Soo K
    J Tradit Chin Med; 2019 Dec; 39(6):800-808. PubMed ID: 32186150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tinospora cordifolia Suppresses Neuroinflammation in Parkinsonian Mouse Model.
    Birla H; Rai SN; Singh SS; Zahra W; Rawat A; Tiwari N; Singh RK; Pathak A; Singh SP
    Neuromolecular Med; 2019 Mar; 21(1):42-53. PubMed ID: 30644041
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Total Glucosides of White Paeony Capsule ameliorates Parkinson's disease-like behavior in MPTP-induced mice model by regulating LRRK2/alpha-synuclein signaling.
    Li HY; Liu DS; Li LB; Zhang YB; Dong HY; Rong H; Zhang JY; Wang JP; Jin M; Luo N; Zhang XJ
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117319. PubMed ID: 37838295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective effects of lithium on a chronic MPTP mouse model of Parkinson's disease via regulation of α‑synuclein methylation.
    Zhao Q; Liu H; Cheng J; Zhu Y; Xiao Q; Bai Y; Tao J
    Mol Med Rep; 2019 Jun; 19(6):4989-4997. PubMed ID: 31059019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
    Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
    Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gami-Chunggan Formula Prevents Motor Dysfunction in MPTP/p-Induced and A53T α-Synuclein Overexpressed Parkinson's Disease Mouse Model Though DJ-1 and BDNF Expression.
    Ahn S; Liu QF; Jang JH; Park J; Jeong HJ; Kim Y; Kim DH; Jeong G; Oh ST; Park SU; Cho SY; Park HJ; Jeon S
    Front Aging Neurosci; 2019; 11():230. PubMed ID: 31555122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-κB signaling pathway.
    Koo JH; Jang YC; Hwang DJ; Um HS; Lee NH; Jung JH; Cho JY
    Neuroscience; 2017 Jul; 356():102-113. PubMed ID: 28527958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.